Connect Has A Best-In-Class Anti-IL-13 In Eczema, But Won’t Be Taking On Apogee Yet Citeline News & Insights Source link
Expectations For Sanofi’s Dupixent Successor Drop On Latest Eczema Data Citeline News & Insights Source link
Roflumilast Promising for AD in Children Down to Age 3 Mos Medscape Source link
It’s Not Just in Your Head: Stress May Directly Worsen Eczema SciTechDaily Source link